The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Open accessAbstract
DNA methylation in promoters is well known to silence genes and is the presumed therapeutic target of methylation inhibitors. Gene body methylation is positively correlated with expression, yet its function is unknown. We show that 5-aza-2'-deoxycytidine treatment not only reactivates genes but decreases the overexpression of genes, many of which are involved in metabolic processes regulated by c-MYC. Downregulation is caused by DNA demethylation of the gene bodies and restoration of high levels of expression requires remethylation by DNMT3B. Gene body methylation may, therefore, be an unexpected therapeutic target for DNA methylation inhibitors, resulting in the normalization of gene overexpression induced during carcinogenesis. Our results provide direct evidence for a causal relationship between gene body methylation and transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased CGI gene body methylation positively correlates with transcriptional activation [6, 25, 55]”
From Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is well-known that promoter CGI hypermethylation represses transcription [43, 45], whereas hypermethylation at gene body CGIs activates gene expression [6, 55].”
From Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that the location of these CGIs determines the direction of this regulation [6, 43, 45, 55]”
From Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Another study demonstrated a positive correlation between gene expression and gene body methylation.55”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“it is widely accepted that the level of methylation in the regions known as CGI regulates gene expression”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,888
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Self-citationCellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 999
Yamazaki, J., Matsumoto, Y., Jelínek, J., Ishizaki, T., Maeda, S., Watanabe, K., Ishihara, G., Yamagishi, J., & Takiguchi, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-89279-0 · Cited by 9
A prelude to the proximity interaction mapping of CXXC5
Ayaz, G., Turan, G., Olgun, Ç. E., Kars, G., Karakaya, B., Yavuz, K., Demiralay, Ö. D., Can, T., Muyan, M., & Yaşar, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-97060-6 · Cited by 9
GLCCI1 gene body methylation in peripheral blood is associated with asthma and asthma severity
Jiang, Y., Xun, Q., Wan, R., Deng, S., Hu, X., Luo, L., Li, X., & Feng, J. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.09.006 · Cited by 9
Shah, V., & Shah, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.835138 · Cited by 9
Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
Yang, Q., Zhu, L., Ye, M., Zhang, B., Zhan, P., Li, H., Zou, W., & Liu, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.805960 · Cited by 9
The regulation of LncRNA GTL2 expression by DNA methylation during sheep skeletal muscle development
Fan, Y., Ren, C., Deng, K., Zhang, Z., Li, J., Deng, M., Zhang, Y., & Wang, F. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110453 · Cited by 9
Exploring the key genes and pathways in enchondromas using a gene expression microarray
Shi, Z., Zhou, H., Pan, B., Lu, L., Kang, Y., Liu, L., Wei, Z., & Feng, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16700 · Cited by 9
Kopparapu, P. K., Morsy, M. H. A., Kanduri, C., & Kanduri, M. (2017) · Oncotarget · doi:10.18632/oncotarget.20668 · Cited by 9
Epigenetic and Epitranscriptomic Factors Make a Mark on Hematopoietic Stem Cell Development
Kasper, D. M., & Nicoli, S. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0113-0 · Cited by 9
Independence between pre-mRNA splicing and DNA methylation in an isogenic minigene resource
Nanan, K. K., Ocheltree, C., Sturgill, D. M., Mandler, M. D., Prigge, M. F., Varma, G., & Oberdoerffer, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx900 · Cited by 7
Cao, R., Ma, B., Yuan, L., Wang, G., & Tian, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01393-7 · Cited by 9
On the prediction of non-CG DNA methylation using machine learning
Sereshki, S., Lee, N., Omirou, M., Fasoula, D. A., & Lonardi, S. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqad045 · Cited by 9
Sibilio, P., Conte, F., Huang, Y., Castaldi, P. J., Hersh, C. P., DeMeo, D. L., Silverman, E. K., & Paci, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31301 · Cited by 8
HOXD12 defines an age-related aggressive subtype of oligodendroglioma
Nuechterlein, N., Cimino, S., Shelbourn, A., Ha, V., Arora, S., Rajan, S., Shapiro, L. G., Holland, E. C., Aldape, K., McGranahan, T. M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02802-1 · Cited by 9
DNA methylation: gene expression regulation
Zmarzły, N., Morawiec, E., Skubis-Sikora, A., Sikora, B., & Mazurek, U. M. (2016) · Acta Universitatis Lodziensis Folia Biologica et Oecologica · doi:10.1515/fobio-2016-0001 · Cited by 10
Li, Z., Ma, Y., Wang, G., Wang, H., Dai, Y., Zhu, Y., Chen, S., Zheng, X., & Sun, F. (2020) · Epigenetics · doi:10.1080/15592294.2020.1749962 · Cited by 8
Takamura, N., Seo, H., & Ohta, K. (2021) · Genes to Cells · doi:10.1111/gtc.12828 · Cited by 8
Zhao, Y., Wu, L., Pang, J., Liao, W., Yu-ji, C., He, Y., & Yang, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.1948949 · Cited by 8
Wei, Z., Duan, X., Li, Q., Li, Q., & Wang, Y. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-541 · Cited by 8
Using empirical biological knowledge to infer regulatory networks from multi-omics data
Pačínková, A., & Popovici, V. C. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04891-9 · Cited by 8
Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities
Craddock, J., Jiang, J., Patrick, S. M., Mutambirwa, S. B. A., Stricker, P. D., Bornman, R. M. S., Jaratlerdsiri, W., & Hayes, V. M. (2023) · Cancers · doi:10.3390/cancers15133462 · Cited by 7
Park, J., Lee, H.-J., Han, Y.-K., Kang, K., & Yi, J. M. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01630-0 · Cited by 7
Epigenetic editing for autosomal dominant neurological disorders
Waldo, J. J., Halmai, J. A. N. M., & Fink, K. D. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1304110 · Cited by 8
Fang, S., Wang, H., Qiu, K., Pang, Y., Li, C., & Liang, X. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1391900 · Cited by 8
Tang, B., Shi, Y., Zeng, Z., He, X., Yu, J., Chai, K., Liu, J., Liu, L., Zhan, Y., Qiu, X., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124194 · Cited by 8
Chen, Y., Marotti, J. D., Jenson, E. G., Onega, T., Johnson, K. C., & Christensen, B. C. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.07.001 · Cited by 8
Chen, L., Dong, Y., Chen, J., Huang, Y., & Zhu, H. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900738 · Cited by 8
Tian, T., Zhang, L., Tang, K., Wang, A., Wang, J., Wang, J., Wang, F., Wang, W., & Ma, X. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5109 · Cited by 8
Mukhopadhyay, S., Ghosh, S., Das, D., Arun, P., Roy, B., Biswas, N. K., Maitra, A., & Majumder, P. P. (2020) · BMC Cancer · doi:10.1186/s12885-020-07709-0 · Cited by 8
Mo, X., Zhang, Y.-H., & Lei, S. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.021 · Cited by 8
Zhang, X., Yang, Y., Zhang, W., Huang, K., Xu, L., Shahid, N., Pan, Y., Xu, C., Jiao, X., & Yang, K. G. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.006 · Cited by 8
Characteristics and functions of DNA N(6)-methyladenine in embryonic chicken muscle development
Yang, M., Leng, D., Zeng, B., Wang, T., Xu, Z., & Li, D. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102528 · Cited by 9
Screening of exon methylation biomarkers for colorectal cancer via LC‐MS/MS strategy
Huang, Q., Yang, Q., Mo, M., Ye, X., Zhang, J., Zhang, L., Chen, B., Li, J., & Cai, C. (2017) · Journal of Mass Spectrometry · doi:10.1002/jms.4032 · Cited by 8
Park, H., Seo, K.-S., Lee, M., & Seo, S. (2019) · Animal Biotechnology · doi:10.1080/10495398.2019.1604378 · Cited by 8
Liu, P., & Tian, W. (2020) · PeerJ · doi:10.7717/peerj.9654 · Cited by 8
Koh, H. W. L., Fermin, D., Choi, K. P., Ewing, R. M., & Choi, H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/374520 · Cited by 8
Krishnan, V. P., Morone, B., Toubiana, S., Krzak, M., Fioriniello, S., Ragione, F. D., Strazzullo, M., Angelini, C., Selig, S., & Matarazzo, M. R. (2023) · Genome Research · doi:10.1101/gr.276986.122 · Cited by 8
Miao, Z., Wu, F., Wei, H., Luo, Z., Wu, K., & Zhang, J. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-00266-5 · Cited by 7
Niinuma, T., KITAJIMA, H., Yamamoto, E., Maruyama, R., Aoki, H., Harada, T., Ishiguro, K., Sudo, G., Toyota, M., Yoshido, A., et al. (2021) · Anticancer Research · doi:10.21873/anticanres.15062 · Cited by 7
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Lavoro, A., Falzone, L., Gattuso, G., Conti, G., Caltabiano, R., Madonna, G., Capone, M., McCubrey, J. A., Ascierto, P. A., Libra, M., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05622-9 · Cited by 7
Walayat, A., Hosseini, M., Nepal, C., Li, Y., Chen, W., Chen, Z., Huang, X., Shao, X. M., Zhang, L., Wang, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75986-x · Cited by 8
Liang, Y., Liu, M., Liu, B., Ziman, B., Peng, G., Mao, Q., Wang, X., Jiang, L., Lin, D., & Zheng, Y. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00570-0 · Cited by 7
Epigenetic Changes Regulating Epithelial–Mesenchymal Plasticity in Human Trophoblast Differentiation
Ackerman, W. E., Rigo, M., DaSilva‐Arnold, S. C., Do, C., Tariq, M., Salas, M. C., Castano, A. M., Zamudio, S., Tycko, B., & Illsley, N. P. (2025) · Cells · doi:10.3390/cells14130970 · Cited by 7
Kamel, E. M., Ali, M. A. M., Allam, A. A., Ahmed, N., Abalkhail, A., Alkhayl, F. F. A., & Lamsabhi, A. M. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01708-9 · Cited by 10
Fuller, A. M., Devine, A., Murazzi, I., Mason, N. J., WEBER, K. L., & Eisinger‐Mathason, T. S. K. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00717-1 · Cited by 7
Jia, W., Li, N., Wang, J., Gong, X., Ouédraogo, S. Y., Wang, Y., Zhao, J., Grech, G., Chen, L., & Zhan, X. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00359-3 · Cited by 7
DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome
Faldoni, F. L. C., Bizinelli, D., Souza, C. P., Santana, I. V. V., Marques, M. M. C., Rainho, C. A., Marchi, F. A., & Rogatto, S. R. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01695-x · Cited by 7
Segura-Ortiz, A., García-Nieto, J., Aldana-Montes, J. F., & Navas‐Delgado, I. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108850 · Cited by 7
Jiang, Y., Yang, H., Ye, Z., Huang, Y., Li, P., Jiang, Z., Han, S., & Ma, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-87038-z · Cited by 8
The Role of Methylation-Specific PCR and Associated Techniques in Clinical Diagnostics
Zhao, F., & Bapat, B. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801899-6.00008-5 · Cited by 7
Aberrant DNA Methylation in Keratoacanthoma
Nobeyama, Y., & Nakagawa, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165370 · Cited by 7
van den Berg, I., Smid, M., van den Braak, R. R. J. C., van de Wiel, M. A., van Deurzen, C. V., de Weerd, V., Martens, J., Ijzermans, J., & Wilting, S. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13098 · Cited by 6
MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
Zhang, X., He, X., Li, Y., Xu, Y., Chen, W., Liu, X., Hu, X., Xiong, L., & Xu, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.702206 · Cited by 7
Discovered Key CpG Sites by Analyzing DNA Methylation and Gene Expression in Breast Cancer Samples
Cao, Y., Li, Q., & Liu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.815843 · Cited by 7
Fabrizio, F. P., Castellana, S., Centra, F., Sparaneo, A., Mastroianno, M., Mazza, T., Coco, M., Trombetta, D., Cingolani, N., Centonza, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.968804 · Cited by 5
Yang, G., Lü, T., Weisenberger, D. J., & Liang, G. (2022) · Genes · doi:10.3390/genes13091555 · Cited by 7
Self-citationHypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer
Zhu, Q., Qiao, R., Di, F., Song, Y., Zhang, J., Tian, X., Wang, Y., Dai, L., Gu, W., Han, B., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.10.014 · Cited by 7
Sprouty4 is epigenetically upregulated in human colorectal cancer
Stuckel, A. J., Zeng, S., Lyu, Z., Zhang, W., Zhang, X., Dougherty, U., Mustafi, R., Khare, T., Zhang, Q., Joshi, T., et al. (2022) · Epigenetics · doi:10.1080/15592294.2022.2145068 · Cited by 7
Role of LncRNA MIR99AHG in breast cancer: Bioinformatic analysis and preliminary verification
Han, W., Shi, C.-T., Chen, H., Zhou, Q., Ding, W., Chen, F., Liang, Z., Teng, Y., Shao, Q., & Dong, X.-Q. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19805 · Cited by 7
Genome-wide DNA methylation profiles of porcine ovaries in estrus and proestrus
Zhou, X.-L., Yang, S., Yan, F., He, K., & Zhao, A. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00052.2017 · Cited by 7
Song, W., Zheng, S., Li, M., Zhang, X., Cao, R., Ye, C., Shao, R., Li, G., Li, J., Liu, S., et al. (2019) · Journal of Asthma · doi:10.1080/02770903.2019.1590589 · Cited by 7
A five‐CpG signature of microRNA methylation in non‐G‐CIMP glioblastoma
Kang, E., Yin, A., He, Y., Chen, W., Etcheverry, A., Aubry, M., Barnholtz‐Sloan, J. S., Mosser, J., Zhang, W., & Zhang, X. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13133 · Cited by 7
Reilly, B. M., Luger, T., Park, S., Lio, C. J., González‐Avalos, E., Wheeler, E. C., Lee, M., Williamson, L. M., Tanaka, T. N., Diep, D. H., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0453 · Cited by 7
Vega‐Tapia, F., Artigas, R., Hernández, C., Uauy, R. D., Casanello, P. C., Krause, B. J., & Castro-Rodríguez, J. A. (2020) · Epigenomics · doi:10.2217/epi-2020-0098 · Cited by 7
McGuire, M. H., Dasari, S. K., Yao, H., Wen, Y., Mangala, L. S., Bayraktar, E., Ma, W., Ivan, C., Shoshan, E., Wu, S. Y., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0753 · Cited by 8
Dai, Y.-H., Wang, Y.-F., Shen, P., Lo, C., Yang, J.-F., Lin, C.-S., Chao, H., & Huang, W.-Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08645-3 · Cited by 9
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas
Darvishi, E., Slemmons, K. K., Wan, Z., Mitra, S. A., Hou, X., Parmentier, J. H., Loh, Y. E., & Helman, L. J. (2020) · Neoplasia · doi:10.1016/j.neo.2020.05.001 · Cited by 7
Endocrine Epigenetics, Epigenetic Profiling and Biomarker Identification
Bertrand-Lehouillier, V., Legault, L., & McGraw, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65830-0 · Cited by 8
Jueterbock, A., Boström, C., Coyer, J. A., Olsen, J., Kopp, M., Dhanasiri, A. K. S., Smolina, I., Arnaud‐Haond, S., de Peer, Y. V., & Hoarau, G. G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/787754 · Cited by 6
The roles of epigenetic regulation in graft-versus-host disease
Wang, Y., Liu, Q., Deng, L., Ma, X., Gong, Y., Wang, Y., & Zhou, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116652 · Cited by 6
Emerging applications of hypomethylating agents in the treatment of glioblastoma (Review)
Silva-Hurtado, T. J., Inocencio, J. F., & Yong, R. L. M. (2024) · Molecular and Clinical Oncology · doi:10.3892/mco.2024.2757 · Cited by 6
Müller, D., & Győrffy, B. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17455 · Cited by 6
Genome-Wide cfDNA Methylation Profiling Reveals Robust Hypermethylation Signatures in Ovarian Cancer
Terp, S. K., Guldbrandsen, K., Stoico, M. P., Mark, L. R., Frandsen, A. P., Dybkær, K., & Pedersen, I. S. (2025) · Cancers · doi:10.3390/cancers17122026 · Cited by 6
Nirgude, S., Desai, S. S., & Choudhary, B. (2022) · BMC Genomics · doi:10.1186/s12864-022-09041-2 · Cited by 6
The Role of FAS Receptor Methylation in Osteosarcoma Metastasis
Sun, J. M., Chow, W.-Y., Xu, G., Hicks, J. M., Nakka, M., Shen, J. J., Ng, P. K. S., Taylor, A. M., Yu, A., Farrar, J. E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512155 · Cited by 6
The impact of site-specific DNA methylation in KCNJ11 promoter on type 2 diabetes
Zhu, M., Huang, Q., Li, H., Zhao, Y., Guo, H., Wang, T., Liu, X., Huang, Y. L., Hu, J., Fang, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39934 · Cited by 8
Mahurkar‐Joshi, S., Thompson, M., Villarruel, E. E., Lewis, J. D., Lin, L. D., Farid, M., Nayeb‐Hashemi, H., Storage, T. R., Weiss, G. A., Limketkai, B. N., et al. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14980 · Cited by 6
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs
Li, W. H., Luo, P., Chen, Q., Cheng, L., Gan, L., Zhang, F., Zhong, H., Zheng, L., & Qian, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1518144 · Cited by 8
Li, X., Fan, D., Li, Y., Yuan, J., Sun, W., Zhu, Q., Qi, L., Wu, X., Cai, J., Gong, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202413508 · Cited by 6
Schamschula, E., Lahnsteiner, A., Assenov, Y., Hagmann, W., Zaborsky, N., Wiederstein, M., Strobl, A., Stanke, F., Muley, T., Plass, C., et al. (2021) · Epigenetics · doi:10.1080/15592294.2021.1959976 · Cited by 5
Sorosina, M., Barizzone, N., Clarelli, F., Anand, S. K., Lupoli, S., Salvi, E., Mangano, E., Bordoni, R., Roostaei, T., Mascia, E., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11109-8 · Cited by 6
Łuczkowska, K., Taryma‐Leśniak, O., Bińkowski, J., Sokolowska, K. E., Strapagiel, D., Jarczak, J., Paczkowska, E., Machaliński, B., & Wojdacz, T. K. (2022) · Cancers · doi:10.3390/cancers14143402 · Cited by 6
Yang, L., Wang, G., Shi, H., Jia, S., Ruan, J., Cui, R., & Ge, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.964902 · Cited by 6
Greve, G., Andrieux, G., Schlosser, P., Blagitko‐Dorfs, N., Rehman, U., Ma, T., Pfeifer, D., Heil, G., Neubauer, A., Krauter, J., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01876-2 · Cited by 8
Wang, N., Jiang, Q.-L., Xie, L., Cheng, B., Liu, Q., & Jiang, R. (2023) · Andrology · doi:10.1111/andr.13465 · Cited by 6
DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer
Duan, C., Yan, Z., Wu, C., Zhou, X., & Bao, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27212 · Cited by 6
Rhee, J., Lee, J. H., Yang, H. K., Kim, T., & Yoon, K. (2017) · Genomics & Informatics · doi:10.5808/gi.2017.15.1.28 · Cited by 6
Overexpression of Fn14 in Gliomas: Tumor Progression and Poor Prognosis
Tan, D., Pang, F.-M., Li, D., Zhang, L., Wu, J., Liu, Z., Li, X., & Han, Y. (2018) · Future Oncology · doi:10.2217/fon-2017-0598 · Cited by 6
Huang, Q., Mukhtar, I., Zhang, Y., Wei, Z., Han, X., Huang, R., Yan, J., & Xie, B. (2019) · Mycobiology · doi:10.1080/12298093.2019.1658332 · Cited by 6
Vougiouklakis, T., Aung, P. P., Vasudevaraja, V., Prieto, V. G., Torres-Cabala, C. A., Sulman, E. P., Snuderl, M., & Jour, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-69787-1 · Cited by 6
Role of DNA methylation in genome stability
Kovalchuk, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00023-4 · Cited by 8
Lin, S., Xu, H., Pang, M., Zhou, X., Pan, Y., Zhang, L., Guan, X., Wang, X., Lin, B., Tian, R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.831268 · Cited by 6
Linares-Pineda, T. M., Peña-Montero, N., Gutiérrez‐Repiso, C., Lima-Rubio, F., Sánchez–Pozo, A., Tinahones, F. J., Molina‐Vega, M., César, M. J. P., & Morcillo, S. (2023) · Epigenetics · doi:10.1080/15592294.2023.2211369 · Cited by 6
Hein, S. D., Thomas, T., Naumova, O. Y., Luthar, S. S., & Grigorenko, E. L. (2018) · Developmental Psychobiology · doi:10.1002/dev.21789 · Cited by 7
Алфимова, М. В., Kondratyev, N. V., Golov, A. K., & Голимбет, В. Е. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.134 · Cited by 6
Induction of DNA Demethylation: Strategies and Consequences
Carollo, P. S., & Barra, V. (2025) · Epigenomes · doi:10.3390/epigenomes9020011 · Cited by 5
Zwartkruis, M. M., Kortooms, J. V., Gommers, D., Elferink, M., Signoria, I., van der Sel, J., Hop, P. J., Zwamborn, R. A. J., Geene, R., Green, J. W., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112461 · Cited by 5
Chen, Y., Zhao, N., Zhang, J., Wu, X., Huang, J., Xu, X., Cai, F., Chen, S., Xu, L., Yan, W., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04164-1 · Cited by 5
Pu, J., Jiang, Y., Xu, B., Zhang, Y., Zhang, W., Yang, D., Sun‐Waterhouse, D., & Li, D. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157352 · Cited by 6
Rethinking Demethylating Agents in Epigenetic Cancer Therapy
Lay, F. D., & Liang, G. (2016) · Journal of Molecular Pharmaceutics & Organic Process Research · doi:10.4172/2329-9053.1000133 · Cited by 5
Self-citation
Metadata
- Authors
- Yang, X., Han, H., De Carvalho, D. D., Lay, F. D., Jones, P. A., & Liang, G.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Jones, Peter A.
- Liang, Gangning
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 26
- Issue
- 4
- Pages
- 577-590
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4224113
- OpenAlex
- W2055986128
- Cited by
- 1,199
- References
- 62
- Citations by year
- 2026: 61 · 2025: 77 · 2024: 104 · 2023: 109 · 2022: 105 · 2021: 120 · 2020: 120 · 2019: 134 · 2018: 128 · 2017: 97 · 2016: 79 · 2015: 55 · 2014: 8
- FWCI
- 32.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Princess Margaret Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA170550, R01CA124518, R01CA082422, P30CA014089, R37CA082422)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- gene body methylation, DNA methylation, decitabine, DNA demethylation, DNMT3B, c-Myc, gene overexpression, transcriptional regulation, DNA methylation inhibitors, cancer therapy, carcinogenesis, metabolic genes
- MeSH terms
- Cell Division, Colonic Neoplasms, Humans, Promoter Regions, Genetic, Gene Expression, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review